RxDoctor Payments Data

Rachel Goodwin

Interventional Cardiology · Knoxville, TNNPI 1295266294

Payments from drug & device makers

What this record shows

This record is dominated by grants: $60,000 of the $73,873 with a category attached, or 81.2%. 24 manufacturers reported payments, led by Medtronic at 43.6% of the total. Reporting peaked in 2024 at $67,258 and has fallen 96.4% since, to $2,450 in 2025.

$73,873in general payments, 2019–2025

Across 222 payments — averaging $332.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$32K
  • Abbott$18K
  • Boston Scientific$16K
  • Edwards Lifesciences$4K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$787
  • Abiomed$421
  • plus $2K from 18 others

What the payments were for

  • Grants$60,00081%
  • Travel & lodging$4,1186%
  • Food & beverage$9,05112%
  • Education$7031%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,873 in reported general payments places this provider in the 85th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee

Other interventional cardiology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →